However, there were exceptions for APL and core binding factor (CBF) AML (i.e., RUNX1-RUNX1T1, CBFB-MYH11), which allowed for the AML diagnosis with a blast count of less than 20% without a specific cut-off value [105]. This evidence concerns the gene CEBPZ and acute myeloid leukemia.